Showing results (51-60 of 175) with videos related to

Sort By:
Pageof 18
Japanese Journal of Clinical Oncology|March 24, 2017
Discomfort during bronchoscopy performed after endobronchial intubation with fentanyl and midazolam: a prospective studyDaisuke Minami, Nagio Takigawa, Hirohisa Kano, et al.
Cancer Science|June 21, 2012
JAK2-related pathway induces acquired erlotinib resistance in lung cancer cells harboring an epidermal growth factor receptor-activating mutationDaijiro Harada, Nagio Takigawa, Nobuaki Ochi, et al.
Respiratory Investigation|January 13, 2021
Comparison of bronchoscopy and computed tomography-guided needle biopsy for re-biopsy in non-small cell lung cancer patientsHirohisa Kano, Toshio Kubo, Kiichiro Ninomiya, et al.
Internal Medicine (Tokyo, Japan)|February 25, 2024
A Prompt Diagnosis and Treatment of a Case of Nuclear Protein of the Testis Carcinoma Characterized by a Bronchial Lesion and High Serum Alpha-fetoprotein Level Following Genomic TestingHiroaki Matsuura, Go Makimoto, Naohiro Oda, et al.
Acta Medica Okayama|October 19, 2017
Protective Effects of Bisoprolol against Acute Exacerbation in Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseAkihiko Taniguchi, Nobuaki Miyahara, Naohiro Oda, et al.
Lung Cancer (Amsterdam, Netherlands)|July 2, 2013
Impact of physical size on gefitinib efficacy in patients with non-small cell lung cancer harboring EGFR mutationsEiki Ichihara, Katsuyuki Hotta, Nagio Takigawa, et al.
Respiratory Investigation|July 15, 2017
Clinical characteristics of Japanese candidates for lung transplant for interstitial lung disease and risk factors for early death while on the waiting listHisao Higo, Takeshi Kurosaki, Eiki Ichihara, et al.
Acta Oncologica (Stockholm, Sweden)|November 30, 2019
Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysisKiichiro Ninomiya, Isao Oze, Yuka Kato, et al.
Japanese Journal of Clinical Oncology|April 8, 2021
A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1RGo Makimoto, Kiichiro Ninomiya, Toshio Kubo, et al.
Case Reports in Oncology|June 15, 2022
Successful and Prompt Treatment with Tepotinib for Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Combined with Lung Abscess Formation: A Case ReportGo Makimoto, Atsushi Shimonishi, Kadoaki Ohashi, et al.
Pageof 18